Showing results (991-1000 of 6,791) with videos related to
Sort By:
Pageof 680
The Journal of Antibiotics|November 2, 2017
New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug developmentMasayuki Igarashi, Yoshimasa Ishizaki, Yoshiaki TakahashiThe Journal of Antibiotics|November 2, 2017
Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positionsYoshinari Wakiyama, Ko Kumura, Eijiro Umemura, et al.The Journal of Antibiotics|November 2, 2017
Cellular uptake of modified aminoglycosidesKaivin Hadidi, Ezequiel Wexselblatt, Jeffrey D Esko, et al.The Journal of Antibiotics|November 2, 2017
Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next stepsVictoria L Simpkin, Matthew J Renwick, Ruth Kelly, et al.The Journal of Antibiotics|November 2, 2017
Synthesis of deoxyelephantopin analoguesRoman Lagoutte, Christelle Serba, Nicolas WinssingerThe Journal of Antibiotics|September 7, 2017
A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2Masatomi Iijima, Yuji Kubota, Ryuichi Sawa, et al.The Journal of Antibiotics|September 7, 2017
Structures and biological activities of novel 4'-acetylated analogs of chrysomycins A and BShun-Ichi Wada, Ryuichi Sawa, Fumiki Iwanami, et al.The Journal of Antibiotics|September 28, 2017
Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screeningJunichi Taira, Koji Morita, Shotaro Kawashima, et al.The Journal of Antibiotics|September 28, 2017
Allostreptomyces indica sp. nov., isolated from IndiaAmit Kumar Sahu, Syed Raziuddin Quadri, Dayanand Agasar, et al.The Journal of Antibiotics|September 21, 2017
Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistanceHeer H Mehta, Amy G Prater, Yousif ShamooPageof 680